ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Proposes To Require Electronic Submission

May 3, 2002

Elm {15 for 17} Has Some Advice For Would Be CCOPs

July 18, 1986

In Brief: CREG To Be Used In Viral Oncology, Nutrition, Cell Kinetics, Immunology, Rauscher Tells NCAB

April 4, 1975

Winship to Open Glenn Family Breast Center

February 7, 2013

In Brief: Administration Backs Down On a Attempt To Kill General Research Support, Will Try To Modify It

November 1, 1974

NCI Tests Early Phase Study To Hasten Drug Development

August 31, 2007